rayner surgical group limited
rayner surgical group limited Company Information
Company Number
00111927
Next Accounts
Sep 2025
Shareholders
macula bidco limited
Group Structure
View All
Industry
Activities of head offices
Registered Address
10 dominion way, worthing, west sussex, BN14 8AQ
Website
www.rayneropticians.co.ukrayner surgical group limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER SURGICAL GROUP LIMITED at £0 based on a Turnover of £0 and 0.5x industry multiple (adjusted for size and gross margin).
rayner surgical group limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER SURGICAL GROUP LIMITED at £0 based on an EBITDA of £-339k and a 3.81x industry multiple (adjusted for size and gross margin).
rayner surgical group limited Estimated Valuation
Pomanda estimates the enterprise value of RAYNER SURGICAL GROUP LIMITED at £1.2m based on Net Assets of £547k and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Rayner Surgical Group Limited Overview
Rayner Surgical Group Limited is a live company located in west sussex, BN14 8AQ with a Companies House number of 00111927. It operates in the activities of head offices sector, SIC Code 70100. Founded in September 1910, it's largest shareholder is macula bidco limited with a 100% stake. Rayner Surgical Group Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Rayner Surgical Group Limited Health Check
There is insufficient data available to calculate a health check for Rayner Surgical Group Limited. Company Health Check FAQs
0 Strong
0 Regular
5 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (7.4%)
- - Rayner Surgical Group Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (110)
- - Rayner Surgical Group Limited
- - Industry AVG
Pay Structure
on an average salary of £97k, the company has a higher pay structure (£49.8k)
- - Rayner Surgical Group Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Rayner Surgical Group Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
- - Rayner Surgical Group Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 99.8%, this is a higher level of debt than the average (55.6%)
- - Rayner Surgical Group Limited
- - Industry AVG
RAYNER SURGICAL GROUP LIMITED financials
Rayner Surgical Group Limited's latest turnover from December 2023 is 0 and the company has net assets of £547 thousand. According to their latest financial statements, Rayner Surgical Group Limited has 1 employee and maintains cash reserves of £756 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 34,891,000 | 41,984,000 | 36,035,000 | 30,394,000 | 25,066,000 | 22,486,000 | 22,985,000 | 43,820,000 | 44,993,000 | 49,473,000 | 48,866,000 | 46,847,000 | |||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 12,845,000 | 16,832,000 | 12,966,000 | 11,607,000 | 9,291,000 | 8,263,000 | 7,765,000 | 13,141,000 | 13,314,000 | 14,906,000 | 14,354,000 | 13,441,000 | |||
| Gross Profit | 22,046,000 | 25,152,000 | 23,069,000 | 18,787,000 | 15,775,000 | 14,223,000 | 15,220,000 | 30,679,000 | 31,679,000 | 34,567,000 | 34,512,000 | 33,406,000 | |||
| Admin Expenses | 21,974,000 | 25,305,000 | 18,431,000 | 16,990,000 | 11,586,000 | 11,865,000 | 13,343,000 | 28,494,000 | 26,307,000 | 27,869,000 | 28,963,000 | 27,443,000 | |||
| Operating Profit | -339,000 | -832,000 | -14,807,000 | 72,000 | -153,000 | 4,638,000 | 1,797,000 | 4,189,000 | 2,358,000 | 1,877,000 | 2,185,000 | 5,372,000 | 6,698,000 | 5,549,000 | 5,963,000 |
| Interest Payable | 5,623,000 | 4,100,000 | 542,000 | 805,000 | 681,000 | 725,000 | 637,000 | 284,000 | 362,000 | 1,343,000 | 1,795,000 | 1,828,000 | 1,482,000 | ||
| Interest Receivable | 1,188,000 | 152,000 | 9,000 | 18,000 | 11,000 | 38,000 | 32,000 | 21,000 | 1,129,000 | 1,775,000 | 64,000 | 1,531,000 | |||
| Pre-Tax Profit | -4,774,000 | -4,781,000 | -15,349,000 | -724,000 | -816,000 | 3,913,000 | 1,160,000 | 3,916,000 | 2,034,000 | 3,410,000 | 1,340,000 | 5,558,000 | 7,186,000 | 5,900,000 | 6,272,000 |
| Tax | 1,016,000 | 252,000 | 147,000 | -381,000 | -778,000 | -500,000 | 49,000 | 250,000 | 731,000 | -1,476,000 | -285,000 | -1,107,000 | -1,747,000 | -1,305,000 | -1,382,000 |
| Profit After Tax | -3,758,000 | -4,529,000 | -15,202,000 | -1,105,000 | -1,594,000 | 3,413,000 | 1,209,000 | 4,166,000 | 2,765,000 | 1,934,000 | 1,055,000 | 4,451,000 | 5,439,000 | 4,595,000 | 4,890,000 |
| Dividends Paid | 136,000 | 333,000 | 1,332,000 | 4,934,000 | 1,480,000 | 1,480,000 | 1,476,000 | 1,408,000 | 1,322,000 | ||||||
| Retained Profit | -3,758,000 | -4,529,000 | -15,202,000 | -1,449,000 | -2,015,000 | 3,413,000 | 1,209,000 | 3,833,000 | 1,433,000 | -3,000,000 | -425,000 | 2,971,000 | 3,963,000 | 3,187,000 | 3,568,000 |
| Employee Costs | 97,000 | 127,000 | 14,306,000 | 14,406,000 | 17,420,000 | 11,207,000 | 9,804,000 | 7,811,000 | 7,429,000 | 9,261,000 | 19,676,000 | 18,049,000 | 18,526,000 | 18,077,000 | 17,736,000 |
| Number Of Employees | 1 | 1 | 5 | 391 | 347 | 248 | 248 | 220 | 202 | 321 | 730 | 787 | 847 | 859 | 885 |
| EBITDA* | -339,000 | -832,000 | -14,807,000 | 4,774,000 | 3,802,000 | 8,510,000 | 4,904,000 | 6,052,000 | 3,524,000 | 2,855,000 | 3,930,000 | 7,083,000 | 8,508,000 | 7,884,000 | 8,465,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 26,270,000 | 28,563,000 | 27,090,000 | 29,767,000 | 30,568,000 | 28,807,000 | 18,520,000 | 13,552,000 | 13,809,000 | 12,470,000 | 11,528,000 | 11,430,000 | |||
| Intangible Assets | 17,645,000 | 16,997,000 | 9,661,000 | 8,861,000 | 7,603,000 | 4,825,000 | 3,120,000 | 6,000 | 8,000 | 13,000 | 432,000 | ||||
| Investments & Other | 22,503,000 | 23,942,000 | 29,694,000 | 168,000 | 511,000 | 511,000 | 979,000 | 466,000 | 420,000 | 364,000 | 333,000 | 264,000 | |||
| Debtors (Due After 1 year) | 580,000 | 833,000 | 4,000 | 3,000 | 1,000 | 1,000 | |||||||||
| Total Fixed Assets | 22,503,000 | 23,942,000 | 29,694,000 | 43,335,000 | 44,727,000 | 36,751,000 | 38,628,000 | 38,171,000 | 33,632,000 | 21,640,000 | 14,024,000 | 14,241,000 | 12,850,000 | 11,862,000 | 12,127,000 |
| Stock & work in progress | 10,378,000 | 10,017,000 | 8,365,000 | 6,842,000 | 6,357,000 | 3,865,000 | 3,266,000 | 6,281,000 | 7,435,000 | 6,458,000 | 5,777,000 | 5,093,000 | |||
| Trade Debtors | 9,154,000 | 10,442,000 | 8,827,000 | 6,753,000 | 6,789,000 | 5,386,000 | 5,289,000 | 4,982,000 | 4,544,000 | 6,016,000 | 4,943,000 | 4,049,000 | |||
| Group Debtors | 303,916,000 | 35,697,000 | 31,773,000 | 519,000 | 385,000 | 424,000 | 393,000 | 330,000 | |||||||
| Misc Debtors | 1,846,000 | 1,545,000 | 165,000 | 1,597,000 | 1,366,000 | 1,306,000 | 1,473,000 | 1,663,000 | 1,952,000 | 3,009,000 | 2,139,000 | 1,761,000 | 1,560,000 | 1,845,000 | 1,568,000 |
| Cash | 756,000 | 1,973,000 | 3,129,000 | 7,133,000 | 5,929,000 | 5,552,000 | 3,479,000 | 1,468,000 | 1,101,000 | 6,872,000 | 5,952,000 | 5,850,000 | 6,607,000 | 5,280,000 | 4,334,000 |
| misc current assets | 400,000 | 133,000 | 468,000 | ||||||||||||
| total current assets | 306,518,000 | 39,215,000 | 35,067,000 | 28,262,000 | 27,754,000 | 24,450,000 | 18,680,000 | 16,745,000 | 12,304,000 | 18,436,000 | 19,873,000 | 19,975,000 | 21,065,000 | 18,238,000 | 15,374,000 |
| total assets | 329,021,000 | 63,157,000 | 64,761,000 | 71,597,000 | 72,481,000 | 61,201,000 | 57,308,000 | 54,916,000 | 45,936,000 | 40,076,000 | 33,897,000 | 34,216,000 | 33,915,000 | 30,100,000 | 27,501,000 |
| Bank overdraft | 212,000 | ||||||||||||||
| Bank loan | 4,310,000 | 260,000 | 270,000 | 1,291,000 | 659,000 | 750,000 | |||||||||
| Trade Creditors | 142,000 | 57,703,000 | 40,000 | 1,853,000 | 1,942,000 | 2,005,000 | 2,029,000 | 2,275,000 | 1,774,000 | 4,687,000 | 2,953,000 | 2,305,000 | 2,941,000 | 3,194,000 | 2,352,000 |
| Group/Directors Accounts | 328,068,000 | 51,405,000 | |||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 825,000 | 1,294,000 | 874,000 | 831,000 | 785,000 | 174,000 | |||||||||
| other current liabilities | 264,000 | 1,511,000 | 3,304,000 | 4,472,000 | 3,082,000 | 1,549,000 | 2,873,000 | 2,063,000 | 2,663,000 | 2,056,000 | 2,611,000 | 3,313,000 | 2,492,000 | 2,699,000 | |
| total current liabilities | 328,474,000 | 57,703,000 | 52,956,000 | 10,292,000 | 7,968,000 | 6,231,000 | 5,700,000 | 6,804,000 | 4,761,000 | 7,350,000 | 5,009,000 | 4,916,000 | 6,254,000 | 5,686,000 | 5,051,000 |
| loans | 36,751,000 | 37,867,000 | 26,175,000 | 22,175,000 | 23,678,000 | 16,842,000 | |||||||||
| hp & lease commitments | 843,000 | 1,491,000 | 1,433,000 | 1,970,000 | 2,110,000 | 671,000 | |||||||||
| Accruals and Deferred Income | 671,000 | ||||||||||||||
| other liabilities | 537,000 | ||||||||||||||
| provisions | 353,000 | 9,950,000 | 12,426,000 | 6,958,000 | 13,070,000 | 13,864,000 | 6,774,000 | 14,146,000 | 377,000 | 403,000 | 409,000 | 273,000 | 300,000 | ||
| total long term liabilities | 353,000 | 26,318,000 | 28,185,000 | 16,879,000 | 17,779,000 | 18,771,000 | 12,345,000 | 7,073,000 | 5,122,000 | 6,377,000 | 4,777,000 | 3,255,000 | 5,072,000 | ||
| total liabilities | 328,474,000 | 57,703,000 | 53,309,000 | 36,610,000 | 36,153,000 | 23,110,000 | 23,479,000 | 25,575,000 | 17,106,000 | 14,423,000 | 10,131,000 | 11,293,000 | 11,031,000 | 8,941,000 | 10,123,000 |
| net assets | 547,000 | 5,454,000 | 11,452,000 | 32,272,000 | 33,685,000 | 38,091,000 | 33,829,000 | 29,341,000 | 28,830,000 | 25,653,000 | 23,766,000 | 22,923,000 | 22,884,000 | 21,159,000 | 17,378,000 |
| total shareholders funds | 547,000 | 5,454,000 | 11,452,000 | 32,272,000 | 33,685,000 | 38,091,000 | 33,829,000 | 29,341,000 | 28,830,000 | 25,653,000 | 23,766,000 | 22,923,000 | 22,884,000 | 21,159,000 | 17,378,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -339,000 | -832,000 | -14,807,000 | 72,000 | -153,000 | 4,638,000 | 1,797,000 | 4,189,000 | 2,358,000 | 1,877,000 | 2,185,000 | 5,372,000 | 6,698,000 | 5,549,000 | 5,963,000 |
| Depreciation | 3,276,000 | 3,028,000 | 2,697,000 | 2,406,000 | 1,525,000 | 970,000 | 894,000 | 1,740,000 | 1,706,000 | 1,806,000 | 1,903,000 | 1,847,000 | |||
| Amortisation | 1,426,000 | 927,000 | 1,175,000 | 701,000 | 338,000 | 196,000 | 84,000 | 5,000 | 5,000 | 4,000 | 432,000 | 655,000 | |||
| Tax | 1,016,000 | 252,000 | 147,000 | -381,000 | -778,000 | -500,000 | 49,000 | 250,000 | 731,000 | -1,476,000 | -285,000 | -1,107,000 | -1,747,000 | -1,305,000 | -1,382,000 |
| Stock | -10,378,000 | 361,000 | 1,652,000 | 1,523,000 | 485,000 | 2,492,000 | 599,000 | -3,015,000 | -1,154,000 | 977,000 | 681,000 | 684,000 | 5,093,000 | ||
| Debtors | 268,520,000 | 5,304,000 | 20,607,000 | -1,310,000 | 2,508,000 | 1,907,000 | -226,000 | 1,114,000 | -960,000 | 658,000 | 946,000 | -1,309,000 | 821,000 | 1,234,000 | 5,948,000 |
| Creditors | -57,561,000 | 57,663,000 | -1,813,000 | -89,000 | -63,000 | -24,000 | -246,000 | 501,000 | -2,913,000 | 1,734,000 | 648,000 | -636,000 | -253,000 | 842,000 | 2,352,000 |
| Accruals and Deferred Income | 264,000 | -1,511,000 | -1,793,000 | -1,839,000 | 2,061,000 | 1,533,000 | -1,324,000 | 810,000 | -600,000 | 607,000 | -555,000 | -702,000 | 821,000 | -207,000 | 2,699,000 |
| Deferred Taxes & Provisions | -353,000 | -9,597,000 | -2,476,000 | 5,468,000 | -6,112,000 | -794,000 | 7,090,000 | -7,372,000 | 13,769,000 | -26,000 | -6,000 | 136,000 | -27,000 | 300,000 | |
| Cash flow from operations | -325,140,000 | 49,915,000 | -38,092,000 | 938,000 | 6,330,000 | -23,000 | 2,330,000 | 11,097,000 | -6,269,000 | 19,846,000 | 3,920,000 | 4,964,000 | 5,963,000 | 5,269,000 | 1,393,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | -2,325,000 | -2,879,000 | -2,785,000 | -2,059,000 | -1,365,000 | ||||||||||
| Change in Investments | -1,439,000 | -5,752,000 | 29,694,000 | -168,000 | 168,000 | -511,000 | -468,000 | 979,000 | -466,000 | 46,000 | 56,000 | 31,000 | 69,000 | 264,000 | |
| cash flow from investments | -2,371,000 | -2,935,000 | -2,816,000 | -2,128,000 | -1,629,000 | ||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -4,310,000 | 4,050,000 | -10,000 | -1,021,000 | 632,000 | -91,000 | 750,000 | ||||||||
| Group/Directors Accounts | 328,068,000 | -51,405,000 | 51,405,000 | ||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -36,751,000 | -1,116,000 | 11,692,000 | 4,000,000 | -1,503,000 | 6,836,000 | 16,842,000 | ||||||||
| Hire Purchase and Lease Commitments | -1,668,000 | -1,117,000 | 478,000 | -494,000 | -94,000 | 2,050,000 | 845,000 | ||||||||
| other long term liabilities | -537,000 | 537,000 | |||||||||||||
| share issue | |||||||||||||||
| interest | -4,435,000 | -3,948,000 | -542,000 | -796,000 | -663,000 | -725,000 | -637,000 | -273,000 | -324,000 | 32,000 | 21,000 | -214,000 | -20,000 | -1,764,000 | 49,000 |
| cash flow from financing | 322,484,000 | -56,822,000 | 2,516,000 | 1,057,000 | 9,106,000 | 2,609,000 | 1,677,000 | 4,663,000 | 20,394,000 | 4,919,000 | 1,289,000 | -3,146,000 | -2,258,000 | -1,170,000 | 13,859,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -1,217,000 | -1,156,000 | -4,004,000 | 1,204,000 | 377,000 | 2,073,000 | 2,011,000 | 367,000 | -5,771,000 | 920,000 | 102,000 | -757,000 | 1,327,000 | 946,000 | 4,334,000 |
| overdraft | -212,000 | 212,000 | |||||||||||||
| change in cash | -1,217,000 | -1,156,000 | -4,004,000 | 1,204,000 | 377,000 | 2,073,000 | 2,223,000 | 155,000 | -5,771,000 | 920,000 | 102,000 | -757,000 | 1,327,000 | 946,000 | 4,334,000 |
rayner surgical group limited Credit Report and Business Information
Rayner Surgical Group Limited Competitor Analysis
Perform a competitor analysis for rayner surgical group limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in BN14 area or any other competitors across 12 key performance metrics.
rayner surgical group limited Ownership
RAYNER SURGICAL GROUP LIMITED group structure
Rayner Surgical Group Limited has 9 subsidiary companies.
Ultimate parent company
2 parents
RAYNER SURGICAL GROUP LIMITED
00111927
9 subsidiaries
rayner surgical group limited directors
Rayner Surgical Group Limited currently has 3 directors. The longest serving directors include Mr Timothy Clover (May 2014) and Mr Alan Hemmant (Mar 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Timothy Clover | United Kingdom | 58 years | May 2014 | - | Director |
| Mr Alan Hemmant | United Kingdom | 43 years | Mar 2023 | - | Director |
| Mr David Allan | England | 60 years | May 2023 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-339k
-59%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
547k
-0.9%
total assets
329m
+4.21%
cash
756k
-0.62%
net assets
Total assets minus all liabilities
rayner surgical group limited company details
company number
00111927
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
September 1910
age
115
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
rayner & keeler limited (August 2014)
accountant
-
auditor
DELOITTE LLP
address
10 dominion way, worthing, west sussex, BN14 8AQ
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
rayner surgical group limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 11 charges/mortgages relating to rayner surgical group limited. Currently there are 4 open charges and 7 have been satisfied in the past.
rayner surgical group limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RAYNER SURGICAL GROUP LIMITED. This can take several minutes, an email will notify you when this has completed.
rayner surgical group limited Companies House Filings - See Documents
| date | description | view/download |
|---|
